Literature DB >> 27352132

Left atrial strain in heart failure with preserved ejection fraction.

S M Aung1, A Güler2, Y Güler2, A Huraibat3, C Y Karabay4, I Akdemir3.   

Abstract

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a syndrome in which patients have symptoms and signs of heart failure but preserved ejection fraction. Left atrial (LA) volume and function are known to be impaired in these patients. Two-dimensional speckle-tracking echocardiography (2D-STE) has recently enabled the quantification of LA deformation dynamics. In this study, we evaluated the use of 2D-STE for the diagnosis of HFpEF. PATIENTS AND METHODS: The study included 83 patients with suspected HFpEF. Patients were divided into two groups after HFpEF had been diagnosed according to current guidelines. Parameters of diastolic dysfunction were evaluated, including left ventricular mass index (LVMI), LA volume index (LAVI), E/A ratio, deceleration time (DT), E/E', and STE parameters such as global longitudinal LA strain during ventricular systole (GLAs-res) and strain during late diastole (GLAs-pump).
RESULTS: The values of BNP, LVMI, DT, LAVI, and GLAs-res were significantly different between the two groups. In univariate analysis, a strong negative correlation was seen between GLAs-res and BNP (r = -0.567, p < 0.001) as well as between GLAs-res and DT (r = -0.665, p < 0.001), while a moderate negative correlation was found between GLAs-res and LVMI (r = -0.458, p < 0.001) and GLAs-res and LAVI (r = -0.316, p = 0.004). In logistic regression analysis, GLAs-res (p = 0.049, OR = 0.71, 95 % CI = 0.451-0.99), BNP (p = 0.025, OR = 1.08, 95 % CI = 1.01-1.14), and LAVI (p = 0.042, OR = 1.59, 95 % CI = 1.02-2.48) were found to be independent predictors of HFpEF.
CONCLUSION: LA function as assessed by 2D-STE is impaired in patients with HFpEF. A GLAs-res value of < 17.5 % can be useful for the diagnosis of HFpEF.

Entities:  

Keywords:  Atrial function, left; Diagnostics; Echocardiography, two-dimensional; Ejection fraction; Heart failure

Mesh:

Year:  2016        PMID: 27352132     DOI: 10.1007/s00059-016-4456-y

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  21 in total

Review 1.  Clinical practice. Diastolic heart failure.

Authors:  Gerard P Aurigemma; William H Gaasch
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

2.  Left atrial volume determination by biplane two-dimensional echocardiography: validation by cine computed tomography.

Authors:  B Kircher; J A Abbott; S Pau; R G Gould; R B Himelman; C B Higgins; M J Lipton; N B Schiller
Journal:  Am Heart J       Date:  1991-03       Impact factor: 4.749

3.  Relationship between left atrial function and size and level of left ventricular dyssynchrony in heart failure patients.

Authors:  Mohammad Sahebjam; Arezou Zoroufian; Hakimeh Sadeghian; Zahra Savand Roomi; Akram Sardari; Shirin Sadat Mirzamani; Masoumeh Lotfi Tokaldany; Arash Jalali
Journal:  Echocardiography       Date:  2013-02-25       Impact factor: 1.724

4.  Left atrial and left ventricular diastolic function in chronic Chagas disease.

Authors:  Cesar Augusto S Nascimento; Victor Augusto M Gomes; Sabrina K Silva; Carla Renata F Santos; Mayara C Chambela; Fabiana S Madeira; Marcelo T Holanda; Pedro Emmanuel A A Brasil; Andrea S Sousa; Sergio S Xavier; Alejandro M Hasslocher-Moreno; Ademir B Cunha; Roberto M Saraiva
Journal:  J Am Soc Echocardiogr       Date:  2013-09-18       Impact factor: 5.251

5.  Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study.

Authors:  R B Devereux; M J Roman; J E Liu; T K Welty; E T Lee; R Rodeheffer; R R Fabsitz; B V Howard
Journal:  Am J Cardiol       Date:  2000-11-15       Impact factor: 2.778

6.  Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.

Authors:  D W Kitzman; J M Gardin; J S Gottdiener; A Arnold; R Boineau; G Aurigemma; E K Marino; M Lyles; M Cushman; P L Enright
Journal:  Am J Cardiol       Date:  2001-02-15       Impact factor: 2.778

7.  Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey.

Authors:  W P Abhayaratna; T H Marwick; W T Smith; N G Becker
Journal:  Heart       Date:  2006-02-17       Impact factor: 5.994

8.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

Authors:  Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert
Journal:  Eur Heart J       Date:  2007-04-11       Impact factor: 29.983

9.  Left atrial deformation and nonischemic dilated cardiomyopathy. A 2D speckle-tracking imaging study.

Authors:  A Guler; K M Tigen; C Dundar; T Karaahmet; C Y Karabay; S M Aung; T Akgun; M Bulut; C Kirma
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

Review 10.  Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure.

Authors:  M Packer
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

View more
  8 in total

Review 1.  Assessment of Left Atrial Function by Echocardiography: Novel Insights.

Authors:  Brian D Hoit
Journal:  Curr Cardiol Rep       Date:  2018-08-27       Impact factor: 2.931

Review 2.  Left atrial strain in left ventricular diastolic dysfunction: have we finally found the missing piece of the puzzle?

Authors:  Giulia Elena Mandoli; Nicolò Sisti; Sergio Mondillo; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

3.  Left atrial function in heart failure with mid-range ejection fraction differs from that of heart failure with preserved ejection fraction: a 2D speckle-tracking echocardiographic study.

Authors:  Lamia Al Saikhan; Alun D Hughes; Wing-See Chung; Maryam Alsharqi; Petros Nihoyannopoulos
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-03-01       Impact factor: 6.875

Review 4.  Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis.

Authors:  Xuanyi Jin; Jan F Nauta; Chung-Lieh Hung; Wouter Ouwerkerk; Tiew-Hwa Katherine Teng; Adriaan A Voors; Carolyn Sp Lam; Joost P van Melle
Journal:  Heart Fail Rev       Date:  2022-01-26       Impact factor: 4.654

5.  Prognostic relevance of left atrial function and stiffness in heart failure with preserved ejection fraction patients with and without diabetes mellitus.

Authors:  Shuangshuang Zhu; Yixia Lin; Yanting Zhang; Guohua Wang; Mingzhu Qian; Lang Gao; Mengmeng Ji; Mingxing Xie; Yuman Li; Li Zhang
Journal:  Front Cardiovasc Med       Date:  2022-09-14

6.  Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction.

Authors:  Yi Zhang; Shen-Yi Li; Juan-Juan Xie; Yuan Wu
Journal:  Clin Cardiol       Date:  2020-03-25       Impact factor: 2.882

7.  Multi-modality machine learning approach for risk stratification in heart failure with left ventricular ejection fraction ≤ 45.

Authors:  Gary Tse; Jiandong Zhou; Samuel Won Dong Woo; Ching Ho Ko; Rachel Wing Chuen Lai; Tong Liu; Yingzhi Liu; Keith Sai Kit Leung; Andrew Li; Sharen Lee; Ka Hou Christien Li; Ishan Lakhani; Qingpeng Zhang
Journal:  ESC Heart Fail       Date:  2020-10-23

Review 8.  Multi-modality assessment and role of left atrial function as an imaging biomarker in cardiovascular disease.

Authors:  Aseel Alfuhied; Prathap Kanagala; Gerry P McCann; Anvesha Singh
Journal:  Int J Cardiovasc Imaging       Date:  2021-06-24       Impact factor: 2.357

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.